Jacobs has confirmed the appointment of John Cronin as Vice President and General Manager, Life Sciences Europe and Michael Donegan as Director of Business Development, Life Sciences Ireland, UK & Nordics.

In his new role, John has responsibility for leading a team of more than 1,300, with a focus on providing world-class Engineering, Procurement, Construction Management, Commissioning and Qualification (EPCMCQ) solutions for Life Sciences clients encompassing Biologics, Cell, and Gene Therapy based manufacturing facilities, Active Pharmaceutical Ingredient (API) manufacturing and related industries.

Based in Ireland, John reports to John Noble, Vice President and General Manager, Global Life Sciences. John joined Jacobs as a senior project manager in 2011 and has held multiple leadership roles within the organization. Most recently, he was Vice President and Executive Project Director, Life Sciences Ireland Operations, where he was responsible for the delivery of several Biologics manufacturing projects involving large-scale production of immuno-oncology medicines.

John brings 36 years of experience managing teams in highly dynamic, high-performance environments to this role. He has particular expertise in full life-cycle industrial project delivery and he has led some of Jacobs’ largest Life Sciences projects, including the Bristol Myers SquibbLarge-Scale Cell Culture Manufacturing Facility in Cruiserath, Dublin, which deployed state‐of‐the‐art project/construction management techniques and tools, was delivered within budget and achieved an impressive safety record on more than 6,500,000 site hours.

John started his career in the UK brewing industry. Prior to joining Jacobs, he served as project manager on multiple Semiconductor and Pharmaceutical/Biotech projects in the US, Norway, Israel, and Ireland, as well as holding a number of Operations roles. John is a Chartered Engineer and Fellow of Engineers Ireland.

Commenting on the appointment, John Noble, Jacobs Vice President and General Manager, Global Life Sciences, said: “We are pleased to announce John’s appointment as Vice President and General Manager, Life Sciences Europe. He steps into this role at a critical period for our global Life Sciences business. As our clients respond to complex and evolving challenges, John’s deep experience in project delivery, coupled with his strategic focus on inclusion, innovation, and sustainability, ensures our business is positioned to deliver holistic solutions on the transformative work we provide.”

Jacobs also confirmed today the appointment of Michael Donegan as Director of Business Development, Life Sciences Ireland, UK & Nordics.  Michael is responsible for new business development in line with Jacobs’ strategy for Life Sciences, with a focus on providing world-class Engineering, Procurement, Construction Management, Commissioning and Qualification (EPCMCQ) solutions for clients encompassing biologics, cell and gene therapy-based manufacturing facilities, Active Pharmaceutical Ingredient (API) manufacturing, and related industries.

Based in Ireland, Michael reports to Sean Sommer, Vice President Business Development & Growth, Advanced Facilities. Michael, who joined Jacobs as a project manager in 2006, brings more than 25 years of experience to his new role. He has held multiple leadership roles within the organization, most recently as Global Director for Performance & Delivery, Advanced Facilities.

Commenting on Michael’s appointment, Sean Sommer said: “We are pleased to announce Michael’s appointment as Director of Business Development, Life Sciences Ireland, UK & Nordics. I am confident that Michael’s proven strategic mindset, leadership ability and his drive and passion for project delivery, quality, and innovation will continue to build and enhance the reputation of our organization.”

Pictured above: John Cronin and Michael Donegan.